Collier Kathryn J
SEC insider (Form 3/4/5 filer). CIK 0001737436. Director at Regulus Therapeutics Inc. (RGLS). 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 25, 2025. Located in SAN DIEGO, CA.
Companies Collier Kathryn J has filed insider reports for
- Regulus Therapeutics Inc. (RGLS): Director
Collier Kathryn J
CIK: 0001737436
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)3 (60.0%)
Derivative conversions
Awards (A)1 (20.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (20.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RGLS
Regulus Therapeutics Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 25, 2025RGLS
Regulus Therapeutics Inc.
DispositionDirect75.6K shares- - Jun 17, 2025RGLS
Regulus Therapeutics Inc.
ExerciseDirect2.6K shares at avg. $9.90$26K - Jun 17, 2025RGLS
Regulus Therapeutics Inc.
ExerciseDirect2.3K shares at avg. $8.80$20K - Jun 16, 2025RGLS
Regulus Therapeutics Inc.
ExerciseDirect1.4K shares at avg. $9.90$14K - Apr 30, 2025RGLS
Regulus Therapeutics Inc.
AwardDirect62.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | Disposition | 75,565 | - | - | Direct |
| Jun 17, 2025 | RGLS Regulus Therapeutics Inc. | Exercise | 2,604 | $9.90 | $25,780 | Direct |
| Jun 17, 2025 | RGLS Regulus Therapeutics Inc. | Exercise | 2,325 | $8.80 | $20,460 | Direct |
| Jun 16, 2025 | RGLS Regulus Therapeutics Inc. | Exercise | 1,396 | $9.90 | $13,820 | Direct |
| Apr 30, 2025 | RGLS Regulus Therapeutics Inc. | Award | 62,500 | - | - | Direct |
1-5 of 5 transactions